119 related articles for article (PubMed ID: 36907429)
1. BZW1 as an oncogene is associated with patient prognosis and the immune microenvironment in glioma.
Zhao L; Song C; Li Y; Yuan F; Zhao Q; Dong H; Liu B
Genomics; 2023 May; 115(3):110602. PubMed ID: 36907429
[TBL] [Abstract][Full Text] [Related]
2. BZW1 promotes cell proliferation in prostate cancer by regulating TGF-β1/Smad pathway.
Shi Z; Xiao C; Lin T; Wu J; Li K
Cell Cycle; 2021 May; 20(9):894-902. PubMed ID: 33886419
[TBL] [Abstract][Full Text] [Related]
3. Adenylate kinase 2 is a biomarker related to the prognosis of glioma and the immune microenvironment.
Liu Z; Tang C; Teng X; Mohamed ZA; Fan J
J Clin Lab Anal; 2023 Apr; 37(8):e24892. PubMed ID: 37161605
[TBL] [Abstract][Full Text] [Related]
4. HOXD9 is a potential prognostic biomarker involved in immune microenvironment of glioma.
Xu S; Xiao H; Song T; Zeng Y; Wei C; Chen T; Hu Z; Guo R; Li D; Jiang M
J Cancer Res Clin Oncol; 2023 Nov; 149(16):14911-14926. PubMed ID: 37603105
[TBL] [Abstract][Full Text] [Related]
5. Expression, oncological and immunological characterizations of BZW1/2 in pancreatic adenocarcinoma.
Ge J; Mu S; Xiao E; Tian G; Tao L; Li D
Front Genet; 2022; 13():1002673. PubMed ID: 36267402
[No Abstract] [Full Text] [Related]
6. Systematic analysis identifies REST as an oncogenic and immunological biomarker in glioma.
Wang G; Yang X; Qi M; Li M; Dong M; Xu R; Zhang C
Sci Rep; 2023 Feb; 13(1):3023. PubMed ID: 36810892
[TBL] [Abstract][Full Text] [Related]
7. CKS2 (CDC28 protein kinase regulatory subunit 2) is a prognostic biomarker in lower grade glioma: a study based on bioinformatic analysis and immunohistochemistry.
Hu M; Li Z; Qiu J; Zhang R; Feng J; Hu G; Ren J
Bioengineered; 2021 Dec; 12(1):5996-6009. PubMed ID: 34494924
[TBL] [Abstract][Full Text] [Related]
8. BZW1 Facilitates Glycolysis and Promotes Tumor Growth in Pancreatic Ductal Adenocarcinoma Through Potentiating eIF2α Phosphorylation.
Li Z; Ge Y; Dong J; Wang H; Zhao T; Wang X; Liu J; Gao S; Shi L; Yang S; Huang C; Hao J
Gastroenterology; 2022 Apr; 162(4):1256-1271.e14. PubMed ID: 34951995
[TBL] [Abstract][Full Text] [Related]
9. Elevated TYROBP expression predicts poor prognosis and high tumor immune infiltration in patients with low-grade glioma.
Lu J; Peng Y; Huang R; Feng Z; Fan Y; Wang H; Zeng Z; Ji Y; Wang Y; Wang Z
BMC Cancer; 2021 Jun; 21(1):723. PubMed ID: 34162355
[TBL] [Abstract][Full Text] [Related]
10. [Single-cell transcriptome analysis of multigrade glioma heterogeneity and immune microenvironment revealed potential prognostic biomarkers].
Liu J; Xu K; Ma L; Wang Y
Sheng Wu Gong Cheng Xue Bao; 2022 Oct; 38(10):3790-3808. PubMed ID: 36305410
[TBL] [Abstract][Full Text] [Related]
11. Long non‑coding RNA NEAT1 modifies cell proliferation, colony formation, apoptosis, migration and invasion via the miR‑4500/BZW1 axis in ovarian cancer.
Xu H; Sun X; Huang Y; Si Q; Li M
Mol Med Rep; 2020 Oct; 22(4):3347-3357. PubMed ID: 32945505
[TBL] [Abstract][Full Text] [Related]
12. PLEKHA4 Is a Prognostic Biomarker and Correlated with Immune Infiltrates in Glioma.
Zhang W; Li L; Bian PP; Luo QP; Xiong ZT
Biomed Res Int; 2023; 2023():4504474. PubMed ID: 36714030
[TBL] [Abstract][Full Text] [Related]
13. BZW1 is a prognostic and immunological biomarker in pancreatic adenocarcinoma.
Luo A; Qiao N; Hu K; Xu H; Xie M; Jiang Y; Hu J
Medicine (Baltimore); 2024 Feb; 103(5):e37092. PubMed ID: 38306570
[TBL] [Abstract][Full Text] [Related]
14. Overexpression of BZW1 is an independent poor prognosis marker and its down-regulation suppresses lung adenocarcinoma metastasis.
Chiou J; Chang YC; Jan YH; Tsai HF; Yang CJ; Huang MS; Yu YL; Hsiao M
Sci Rep; 2019 Oct; 9(1):14624. PubMed ID: 31601833
[TBL] [Abstract][Full Text] [Related]
15. MXRA5 Is a Novel Immune-Related Biomarker That Predicts Poor Prognosis in Glioma.
Sun JZ; Zhang JH; Li JB; Yuan F; Tong LQ; Wang XY; Chen LL; Fan XG; Zhang YM; Ren X; Zhang C; Yu SP; Yang XJ
Dis Markers; 2021; 2021():6680883. PubMed ID: 34211612
[TBL] [Abstract][Full Text] [Related]
16. Role of COL6A2 in malignant progression and temozolomide resistance of glioma.
Hong X; Zhang J; Zou J; Ouyang J; Xiao B; Wang P; Peng X
Cell Signal; 2023 Feb; 102():110560. PubMed ID: 36521657
[TBL] [Abstract][Full Text] [Related]
17. miR-139 Functions as An Antioncomir to Repress Glioma Progression Through Targeting IGF-1 R, AMY-1, and PGC-1β.
Wang H; Yan X; Ji LY; Ji XT; Wang P; Guo SW; Li SZ
Technol Cancer Res Treat; 2017 Aug; 16(4):497-511. PubMed ID: 26868851
[TBL] [Abstract][Full Text] [Related]
18. Bioinformatic Profiling of Prognosis-Related Genes in Malignant Glioma Microenvironment.
Li Y; Deng G; Qi Y; Zhang H; Gao L; Jiang H; Ye Z; Liu B; Chen Q
Med Sci Monit; 2020 Aug; 26():e924054. PubMed ID: 32843610
[TBL] [Abstract][Full Text] [Related]
19. Coiled-coil domain containing 109B is a HIF1α-regulated gene critical for progression of human gliomas.
Xu R; Han M; Xu Y; Zhang X; Zhang C; Zhang D; Ji J; Wei Y; Wang S; Huang B; Chen A; Zhang Q; Li W; Sun T; Wang F; Li X; Wang J
J Transl Med; 2017 Jul; 15(1):165. PubMed ID: 28754121
[TBL] [Abstract][Full Text] [Related]
20. TCAF2 is associated with the immune microenvironment, promotes pathogenesis, and impairs prognosis in glioma.
Li Y; Li J; Chen H; Lu B; Lu F; Chen H; Liu H; Qian C
Gene; 2023 Oct; 883():147667. PubMed ID: 37506986
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
